This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 Set to Soar

Ziopharm Oncology

Another under-$10 name that's trading very close to triggering a near-term breakout trade is Ziopharm Oncology (ZIOP - Get Report), a biopharmaceutical company engaged in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies. This stock is off to a decent start in 2012, with shares up around 16% on the year.

>>22 Biopharma Stocks With Breakout Potential in 2012

If you take a look at the chart for Ziopharm Oncology, you'll notice that this stock recently dropped sharply from around $4.75 to a low of $3.36 a share with heavy volume. Following that plunge, shares of ZIOP have rebounded sharply to its current price of around $5.10 a share. That rebound is quickly pushing ZIOP within range of triggering a near-term breakout trade.

Market players should now look for long-biased trades in ZIOP if it can manage to trigger a break out above some near-term overhead resistance levels at $5.31 to $5.75 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 639,378 shares. If that breakout triggers soon, then ZIOP will setup to re-test or possibly take out its next major overhead resistance levels at $6.02 to $6.33 a share. Any high-volume move above $6.33 will put $7 to $7.85 into focus for ZIOP.

Traders can look to buy ZIOP off any weakness, and simply use a stop that sits just below some near-term support at $5 a share. One could also buy ZIOP once it clears its 50-day at $5.20 with high volume. Look to add to either position once ZIOP takes out $5.31 to $5.75 a share, and then once it clears $6.02 to $6.33 a share with high volume.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
MOTR $1.92 -0.52%
ZIOP $5.10 0.00%
EGHT $11.62 0.00%
MDGN $3.32 0.00%
AAPL $94.02 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs